Evidence map›Paper›PMID 41898368›Full record

ArticleBiomedicines2026

Pan-Cancer Analysis Identifies SNORA12 as a Prognostic Biomarker and Demonstrates Its Role in Upregulating TIGIT in Osteosarcoma.

Weiwei He, Wenbo Shi, Qian Li, Baiguang Yu, Jia Song, Marina Igorevna Sekacheva, Haiyan Hu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Selective remodeling of snoRNA and sdRNA biology in glioblastoma.Frontiers in cell and developmental biology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Weiwei HeClinical Research Ward, The Sixth People's Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.ORCID 0000-0002-4147-9826
Wenbo ShiClinical Research Ward, The Sixth People's Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
Qian LiClinical Research Ward, The Sixth People's Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
Baiguang YuClinical Research Ward, The Sixth People's Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
Jia SongClinical Research Ward, The Sixth People's Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
Marina Igorevna SekachevaDepartment of Innovative Healthcare Development, Institute of Personalized Oncology, Sechenov University, 119991 Moscow, Russia.
Haiyan HuClinical Research Ward, The Sixth People's Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.ORCID 0000-0002-3993-974X

Funding

National Natural Science Foundation of China 82373391 and 82072967 (H.H.), 82073266 and 82273471 (Z.Z.), 82072962 (Y.D.), 82102866(Y.Z.)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerosteosarcomaSNORA12

Identifiers

PMID41898368
PMCPMC13024225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.